搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
pharmaphorum
1 天
FDA clears Ionis drug as first therapy for rare disease FCS
Ionis Pharma's olezarsen has become the first FDA-approved drug therapy for adults with familial chylomicronaemia syndrome ...
pharmaphorum
1 天
Novo Nordisk sheds billions in value on obesity data
Novo Nordisk and Eli Lilly are currently a duopoly in the obesity market, which reached a value of $24 billion last year ...
pharmaphorum
1 天
Lilly grabs first-ever FDA nod for a sleep apnoea drug
Eli Lilly's Zepbound has become the first drug to be FDA-approved for obstructive sleep apnoea (OSA), a sleep-related ...
pharmaphorum
1 天
PBM reform dropped in Congress' funding package
The stripping of the legislation from the short-term funding package was described as a "missed opportunity" by the National ...
pharmaphorum
5 天
UnitedHealth killing suspect gets first-degree murder charge
First-degree murder charges are applied when there is suspicion of premeditated, intentional killing, while second-degree ...
pharmaphorum
5 天
Lilly's Alzheimer's drug Kisunla is cleared in China
China is the fourth major market where Kisunla has been approved after the US, Japan, and GB. It gets the green light there ...
pharmaphorum
4 天
Neuralink rival Precision raises $102m, and other financings
While Neuralink has been grabbing headlines due to its association with controversial billionaire Musk, other companies - ...
pharmaphorum
12 天
Drug-digital dual therapy for depression starts phase 2
Apimostinel has a similar mode of action to ketamine and derivatives like Johnson & Johnson's Spravato (esketamine) – ...
pharmaphorum
6 天
PBM reform looms in end-of-year US legislation package
Specifically, that could include a ban on spread pricing – when a PBM reimburses pharmacies one price for a medicine, but ...
pharmaphorum
7 天
Galderma adds new indication for blockbuster hope Nemluvio
Dermatology specialist Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to ...
pharmaphorum
4 天
How small molecule-focused CDMOs can navigate the impact of the Inflation Reduction Act
The 2022 Inflation Reduction Act (IRA) has introduced significant challenges for the pharmaceutical industry, altering the ...
pharmaphorum
2 天
A history of Pfizer
Few companies embody the term 'pharma giant' as much as Pfizer. Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈